Library / Blends / BPC-157 + Thymosin α1
Repair + immune-modulating pair
BPC-157 + Thymosin α1
Blend
ClassTwo-peptide stack
Typical routes in papersSC
Half-life contextPer component
EvidenceParts; TA1 has regional immune labels
What it is
A pairing of BPC-157 with thymosin alpha-1 (thymalfasin / Zadaxin-class). Pitched as tissue repair plus T-cell signaling, not a named comic-book blend.
Benefits in plain language
What researchers and reference users usually mean when they talk about this compound. These are study themes and common claims — not a promise that it will do this in you.
- What people want: Wolverine-style repair plus an immune-modulating thymic peptide.
- TA1 is immunology, not a tendon peptide. Don’t flatten it into “more BPC.”
- See both solo pages.
If a branded, FDA-approved product exists, that label is the only dose that is actually authorized. Research-chemical vials are a different object.
Mechanism of action
BPC-157 cytoprotection models; TA1 thymic / interferon-adjacent immune modulation.
Possible side effects / caveats
Immune-active peptide plus an unapproved repair peptide. Infection-timing and autoimmune caution belong on the TA1 side.
Protocol ranges
| Source tier | Amount | Frequency / duration | Notes |
|---|---|---|---|
| Cited as stack | BPC daily-class + TA1 several times weekly | Separate vials more honest than one cake | Community |
| See also | BPC-157, Thymosin alpha-1 | Parts |
Numbers below and above are literature or community pointers, not a treatment plan. Approved products, when they exist, follow the official label — not a research vial.